Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 935

Trace Genomics to grow with $13m

The soil analytics provider took its total funding to $19m in a round featuring agricultural investment, data and media platform AgFunder.

Nov 15, 2018

Ucommune absorbs $200m of series D cash

Ucommune, a China-based workspace provider backed by corporates including Prosperity Holdings, Junfa Group and Dahong Group, has now raised $715m altogether.

Nov 15, 2018

LeanTaas gets more Insight in $15m round

LeanTaas, which counts Sedgwick Claims Management Services as an investor, closed a series C round led by Insight Venture Partners that will fund the growth of its platform.

Nov 15, 2018

University Ventures enrols in Unicaf’s latest round

Online higher education platform Unicaf has raised series B funding from a consortium also including Goldman Sachs, EdX and CDC Group as it gears up to target more students.

Nov 15, 2018

Crossword looks to Aim for clues

The cybersecurity commercialisation firm hopes to raise $2.9m through an Aim placement and will use the funding for product development, working capital, sales and marketing.

Nov 15, 2018

Kebotix collects $5m

Kebotix has emerged from Harvard University with backing from investors including Baidu to commercialise an automated approach to discovering new materials and molecules.

Nov 15, 2018

UiPath reaches $265m series C close

Enterprise automation software provider UiPath has added $40m to a round co-led by existing investor CapitalG that values it at $3bn.

Nov 15, 2018

Nikola inflates series C round to $210m

Nikola Corporation has doubled the size of a Nel-backed round to $210m, valuing it at $1.3bn post-money as it gears up to launch its hydrogen-powered semi-truck.

Nov 15, 2018

NextCure looks forward with $93m

Strategic partner Eli Lilly invested $15m while Pfizer, Ping An Ventures and Taiho Ventures also contributed to the immunotherapy developer's series B round.

Nov 15, 2018

Kymera reels in $65m

Pfizer Ventures and 6 Dimensions Capital joined Merck & Co, Sanofi, Eli Lilly and Amgen in Kymera's series B round, taking the protein degradation drug developer's total funding to more than $95m.

Nov 15, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here